Presentations

2025   Anti-seizure levels: Pharmacokinetics & Pharmacodynamic modeling, Part of the symposium: Approach to anti-seizure level monitoring during pregnancy, American Epilepsy Society Annual Meeting, Women in Epilepsy SIG, December 7, 2025.

2025   Pharmacy SuRGE Webinar presenter and moderator, Alternative Models for Research Support, American Association of Colleges of Pharmacy (AACP), September 16, 2025.

2025   Leveraging Precision Medicine to Optimize Antiseizure Medications in Pediatrics and Pregnancy, Part of the symposium: Revolutionizing Clinical Pharmacology in Maternal & Pediatric Populations: Vital Resources & Innovative Strategies. American College of Clinical Pharmacology Annual Meeting Symposium, September 14, 2025.

2025   Medical Laboratory Sciences graduation keynote speaker, September 12, 2025.

2025   Dosage, Efficacy, and Adverse Events of Medical Cannabis in Minnesota Residents, Cannabis Research Center, School of Public Health, University of Minnesota, September 20, 2025.  

2023   Pharmacokinetics in Older Adults with Epilepsy, Epilepsy and Aging: Unique Aspects of Epilepsy in Aging, AES Aging SIG, December 4, 2023.  

2023   Translational Clinical Neuropharmacology: Special Populations, Accelerating Research, Faculty Presenter, University of Minnesota, July 31, 2023.

2023   Translational Research in the College of Pharmacy, Summer Undergraduate Experience Program (SCoPE) program,

2023   Pharmacokinetic considerations of medications used to treat catamenial epilepsy, part of the Challenges of Contraception in Epilepsy American Epilepsy Workshop, Brigham and Women’s Hospital in Boston, invited speaker, April 14, 2023.

2022   Development of Vaccines for the Treatment of Opioid Use Disorder, Innovations in Therapeutic Care for Opiate Use Disorder and Pain – From Vaccines to Precision Therapeutics session, Symposium at the American Society of Clinical Pharmacology Therapeutics 2022 Annual Meeting, invited, March 16, 2022.

2022   Medical Cannabis in Neurology: Pharmacokinetics Application and evidence, Spring into Cannabis, CME, Bloomington, MN, April 7, 2022.

2021   Lamotrigine Pharmacokinetics During Pregnancy, Postpartum, and Breastfeeding, Experimental and Clinical Pharmacology seminar, University of Minnesota, October 20, 2021.

2021   Drug Exposure Changes in the Antiseizure Medication Lamotrigine During Pregnancy, Department of Pharmacology Seminar Series, University of Minnesota, October 15, 2021.

2021   Pharmacokinetics of the Most Commonly Prescribed Antiseizure Medications Received During Pregnancy and Postpartum, online, MINCEP-UMP, September 8, 2021.

2021   Translational Research in Special Populations, Invited seminar, Butler University, College of Pharmacy, Indianapolis, Indiana, virtual April 22, 2021.

2020   Pharmacokinetics of Cannabidiol: Food Effect, online, Vireo journal club, October 22, 2020.

2020   Abuse Potential of Cannabidiol (CBD), American Epilepsy Society PRO Journal Club, online, September 10, 2020.

2019   Pharmacokinetics of Antiepileptic Drugs in Pregnant Women: Latest and Emerging Data, Part of the Presidential Symposium, American Epilepsy Society, December 7, 2019.

2018   Pharmacokinetic Changes in Antiseizure Drugs During and Post Pregnancy, MINCEP Epilepsy Care, St. Louis Park, MN, June 13, 2018.

2017   Pharmacokinetic Laboratory Core MONEAD investigator’s meeting update, Webinar, May 25, 2017.

2017    Food effect on cannabiodiol pharmacokinetics in adult refractory epilepsy patients, 2017.

2017    Correlation of lamotrigine clearance and estradiol concentrations during the first trimester of pregnancy,  2017.

2017    Cannabidiol clearance by P450 is markedly different between human and dog liver microsomes, 2017.

2017    First sodium level post carbamazepine use is predictive of future sodium levels,  2017.

2017    Individual Differences in Working Memory Capacity and Topiramate-induced Cognitive Impairment,  2017.

2017    Fluent Speech in the Presence of Severe Verbal Working Memory Dysfunction, 2017.

2017    Efficacy of heroin and oxycodone vaccines for reducing opioid distribution to brain over a range of drug doses in rats, 2017.

2016   Antiepileptic Drug Exposure in Children of Breastfeeding Mothers with Epilepsy,  Dec 4, 2016.  *Highlighted abstract: Editorial/interview Neurology Today.

2016   Medical Cannabis and the FDA, Clinical and Translational Science Institute, September 7, 2016. 

2016   Pharmacokinetic and Cognitive Side Effects of Cannabidiol in Adult Patients, Epilepsy Foundation webinar, August 16, 2016.

2016   Medical Cannabis: Research Roundtable, invitation only, The Minnesota Department of Health Office of Medical Cannabis/University of Minnesota, MN, April 29, 2016.

2016   Medical Cannabis in Neurology: Pharmacokinetics; part of continuing education program - Medical Cannabis: Clinical Applications and Evidence for Health Professionals, Continuing Education Credit, The Minnesota Department of Health Office of Medical Cannabis/University of Minnesota Center for Spirituality & Healing, April 28, 2016.

2016    Impact of Correlation Structure Assumptions on Model-Based Meta-Analysis of Aggregate Longitudinal Data, 2016. 

2016    Iron Supplementation Decreases Carbamazepine Bioavailability in Elderly Nursing Home Residents, 2016.

2016    Topiramate effects on fluency of spontaneous speech,  2016.

2016    Clearance changes of lamotrigine during pregnancy are detectable within the first trimester of pregnancy, 2016.

2016    Language deficits induced by topiramate (TPM) administration, 2016.

2015    The Relationship of Co-medications and Charlson Scores in Elderly Nursing Home Residents Receiving Antiseizure Drugs, December 2015.

2015    Changes in Antiseizure, Antidepressant, and Antipsychotic Prescribing in Elderly Nursing Home Residents, December 2015.

2015    An R package that faciliates pharmacometrics workflow of Phoenix NLME analyses, Oct. 2015.

2015   Antiseizure Drugs in Elderly Patients, Midwest Seizure Smart Conference, Epilepsy Foundation of Minnesota,  July 2015.

2015   Pharmacokinetic Core Laboratory: Maternal Outcomes & Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD), Investigator’s Meeting,  2015.

2014   Computerized Language and Speech Analysis to Measure Effects of Anti-epileptic Drugs on Cognition, 2014. 

2014    Prevalence of Epilepsy as a Co-Morbidity with Stroke in the US,  December 2014.

2014    Commonly Prescribed Antiepilepsy Drugs in Nursing Home Elderly Residents, December 2014.  *Highlighted in Presidential Symposium as effecting clinical practice

2014    Pharmacotherapy in the Elderly, American Epilepsy Special Interest Group, American Epilepsy Society Annual Meeting, December 2014. 

2014     Variability in Drug Exposure in Special Populations, November 22, 2014. 

2014    Population Pharmacokinetic-Pharmacodynamic Model of Topiramate Effect on Working Memory in Healthy Volunteers, October 12-15, 2014. 

2014    Pharmacokinetics-Pharmacodynamics Modeling of Topiramate’s Effect on Working Memory in Healthy Volunteers, March 24, 2014. *Awarded best poster 

2014    Exploring Factors to Determine the Impact of Fluctuating Epilepsy Drug Concentrations in Elderly Nursing Home Patients, Clinical and Translational Science Institute, Advanced Research Program, September 15, 2014.

2013     "Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD), Biological Sample Collection, Processing, and Shipping," January 26, 2013. 

2013     "Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD), Pharmacokinetics Core," January 25, 2013.

*American Society for Clinical Pharmacology and Therapeutics Presidential Trainee Award - Indicated as one of the Top Trainee Abstracts - http://www.ascpt.org/ASCPT-2016-Annual-Meeting/Showcase-of-Top-Trainee-Abstracts

*ASCPT posted video - https://www.youtube.com/watch?v=3eJ4vpBgaUY